-transparent.png){kind=logo}
Serum alpha(1----3)-L-fucosyltransferase activity was measured in 29 ovarian cancer patients with active disease, 26 ovarian cancer patients with no clinical evidence of disease and 23 healthy females. N-Acetyl-2'-O-methyl-lactosamine was used as the acceptor for the enzyme. The level of the enzyme activity was significantly (P less than 0.05) higher in the serum of patients with known tumor when compared to healthy controls and patients with no clinical evidence of disease.
Related Publications
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
July 1987,
European journal of cancer & clinical oncology,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
January 1989,
Journal of cancer research and clinical oncology,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
December 1991,
Clinical chemistry,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
August 1985,
Cancer research,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
December 1989,
Cancer,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
February 1992,
The Journal of biological chemistry,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
November 1992,
The Journal of biological chemistry,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
October 1995,
Glycoconjugate journal,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
April 1992,
Archives of biochemistry and biophysics,
R Madiyalakan, and
S Yazawa, and
J J Barlow, and
K L Matta
July 1988,
Carbohydrate research,
